Renal and Transplant Medicine Symposium

Abstract

Get full access to this article

View all access options for this article.

References

McCullough

Sharma

Ali

Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function. Nephrol Dial Transplant 2012; 27:1812–21. http://dx.doi.org/10.1093/ndt/gfr547

Gansevoort

Correa-Rotter

Hemmelgarn

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382:339–52. http://dx.doi.org/10.1016/S0140-6736(13)60595-4

Kottgen

Pattaro

Boger

New loci associated with kidney function and chronic kidney disease. Nature Gen 2010; 42:376–84. http://dx.doi.org/10.1038/ng.568

Macdougall

Fishbane

Duliege

AM.

Peginesatide for anemia in chronic kidney disease. N Engl J Med 2013; 368:1553–4. http://dx.doi.org/10.1056/NEJMoa1203166

Smith

Robbins

Ratcliffe

PJ.

The human side of hypoxiainducible factor. Br J Haematol 2008; 141:325–34. http://dx.doi.org/10.1111/j.1365-2141.2008.07029.x

Schwoebel

Van Eijk

Zboralski

The effects of the antihepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys. Blood 2013; 121:2311–5. http://dx.doi.org/10.1182/blood-2012-09-456756

Stock

Barin

Murphy

Outcomes of kidney transplantation in HIV-infected recipients. New Engl J Med 2010; 363:2004–14. http://dx.doi.org/10.1056/NEJMoa1001197

Schrier

Gross

Gheorghiade

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. New Engl J Med 2006; 355:2099–112. http://dx.doi.org/10.1056/NEJMoa065181